查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
神经刺激设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、应用、最终用户和地理位置
市场调查报告书
商品编码
1372498

神经刺激设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、应用、最终用户和地理位置

Neurostimulation Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 172 Pages | 订单完成后即时交付

价格

神经刺激设备市场预计将从2022 年的58.02 亿美元增至2030 年的118.25 亿美元。预计2022 年至2030 年，该市场将以9.3% 的复合年增长率增长。神经系统疾病的患病率不断上升，脊椎疾病病例不断增加脊髓损伤是神经刺激设备市场发展的关键驱动因素。然而，缺乏专业人士正在阻碍神经刺激设备市场的成长。

非侵入性治疗需求不断成长将推动未来神经刺激设备市场的发展

神经刺激是一个快速发展的领域，它利用神经系统的有针对性的电、机械、磁或热刺激来改变放电神经元和内部神经元连接的特性，以治疗各种神经系统疾病。非侵入性神经刺激装置包括电惊厥治疗（ECT）、经皮神经电刺激（TENS）、经颅电刺激（TES）、经颅直流电刺激（tDCS）、经颅交流电刺激（tACS）、静磁刺激、随机声音刺激、週边刺激等。神经刺激、超音波和聚焦超音波 (FUS)，包括脑神经刺激。非侵入性神经刺激技术是精神科领域最发达的技术。

患者和医疗保健提供者越来越喜欢非侵入性或微创治疗方案，因为它们方便、无痛、安全且副作用最小。此外，它也广泛应用于神经系统疾病。非侵入性治疗旨在改善生活品质并减少言语、吞嚥和认知问题的影响。因此，对非侵入性治疗的需求不断增长将极大地推动未来神经刺激设备市场的成长。

政府正在对人们进行有关中风的教育，并提供改进的治疗、医疗技术、增强的医疗保健覆盖范围和医疗保健环境。此外，国家也增加了非传染性疾病防治的投入。此外，根据世界卫生组织的资料，中国约有95%的人口在农村和城市地区参保，政府针对低收入群体推出了两项保险计划：新型农村合作医疗制度（NRCMS）和城镇居民保险。基本医疗保险（城镇居民基本医疗保险）。这些计划的启动是因为健康费用是大多数人的重要支出之一。中国政府的这些措施将鼓励人们接受手术以改善健康。由于日本和中国等国家医疗器材产业的不断发展，神经刺激设备市场也有望成长。此外，神经病学的创新技术趋势以及人工智慧（AI）和机器学习（ML）的快速采用是推动该地区市场的几个因素。

此外，该国神经刺激设备市场的成长归因于中风盛行率的上升和发病率的增加。神经外科需要先进的设备和高素质的医疗专业人员。德国拥有高素质的神经外科医生；他们遵循最新的方案和手术程序。该国的神经病学中心拥有符合国际品质标准的最现代化的诊断和微创手术设备。

根据伦敦国王学院为欧洲中风联盟所做的《欧洲中风负担》报告中公布的资料，德国每年记录约88,922例中风病例，即每10万居民中风51.7例。德国的中风盛行率约为 526,774 人，每 10 万名居民中有 338.5 人中风。德国的中风死亡率也很高，每年有 75,861 人死于中风。根据《欧洲中风负担》报告，预计2035年，中风病例将增加30%，到2035年底，中风盛行率将增加至19%。德国约有40万人受到这种疾病的影响。2022年12月，由于人口老化，这数字还在增加。越来越多的人，包括年轻人，患有神经退化性疾病；在德国，超过 200 万人患有痴呆症或帕金森氏症。根据德国阿兹海默症患者协会统计，2020年，阿兹海默症导致9,450人死亡，创历史新高。阿兹海默症住院人数和死亡人数的增加很大程度上取决于德国人口老化。在德国，65 岁及以上人口增加了约 33%，到 2020 年达到 1,830 万人。

因此，中风发病率显着增加和人口老化导致神经系统疾病病例不断增加，推动了德国神经刺激设备市场的成长。此外，政府的支持性措施和神经病学研究也促进了市场成长。因此，上述因素可能会促进 2022-2030 年神经刺激设备市场的成长。

神经刺激设备市场根据产品、应用、最终用户和地理位置进行细分。根据产品，市场分为脊髓刺激器、深部脑部刺激器、荐神经刺激器、迷走神经刺激器等。脊髓刺激器细分市场在 2022 年占据更大的市场份额，预计 2022 年至 2030 年期间复合年增长率将更高。神经刺激设备市场依应用分为疼痛管理、癫痫、尿失禁、大便失禁、帕金森氏症等。疼痛管理领域在 2022 年占据了更大的市场份额，预计 2022 年至 2030 年期间复合年增长率将更高。依最终用户划分，神经刺激设备市场分为医院、专科诊所等。医院细分市场在 2022 年占据最大市场份额，预计专科诊所细分市场在 2022 年至 2030 年期间将实现最高的复合年增长率。专科诊所是确保提供高标准临床结果的卓越中心。这些中心致力于诊断、治疗和管理神经系统疾病，并聘请训练有素、具有专业技能的医生、护理人员和护理人员。除了使用高阶设备遵守预先定义的协议之外，更好的服务品质比其他设施更能为患者增加价值。这些诊所简化了服务并增强了便利的照护。

此外，专科诊所在轻鬆、平静的环境中提供医学建议和监督的治疗。除了提供多种诊断程序外，这些诊所还帮助人们了解帕金森氏症、阿兹海默症、震颤和其他此类疾病患者的日常护理程序。这些患者可能会透过服用有间隙的药物来接受运动症状测试，以评估疾病的严重程度。成本效益和较短的等待时间等因素推动了该细分市场的成长。

这些疾病在全球范围内的盛行率上升，导致越来越多的患者前往专科诊所诊断和治疗这些疾病，全球越来越多的专科诊所提供更好的治疗和专业服务。此外，市场成长归因于全球专科诊所渗透率的不断增长。例如，2022年7月，俄亥俄州立大学韦克斯纳医学中心的神经病学团队开设了一个新的专科诊所，即帕金森氏症多学科诊所。该诊所充当帕金森氏症患者的“一站式商店”，让他们获得所需的所有护理，而无需在不同地点进行多次预约。在诊所，患者可以与治疗师、神经心理学家、经过专业培训的运动神经学家和高级实践提供者组成的团队一起解决僵硬、记忆困难、不稳定/协调性差、震颤和疲劳等症状。

美国食品药物管理局 (FDA)、国家癌症研究所 (NCI)、卫生和预防部 (MoHAP) 和国家转型计划 (NTP) 是在准备神经刺激报告时参考的一些主要和次要来源设备市场。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 神经刺激设备市场（依地理位置）

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：神经刺激设备市场格局

  • 概述
  • PEST分析
    • 全球PEST分析

第 5 章：神经刺激设备市场 - 主要产业动态

  • 市场驱动因素
    • 神经系统疾病的盛行率不断增加
    • 脊髓损伤病例不断增加
  • 市场限制
    • 缺乏专业人才
  • 市场机会
    • 神经刺激设备的不断进步和批准
  • 未来的趋势
    • 对非侵入性治疗的需求不断增长
  • 影响分析

第 6 章：神经刺激设备市场 - 全球市场分析

  • 神经刺激设备市场收入，2022 - 2030

第 7 章：全球神经刺激设备市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 2022 年及 2030 年神经刺激设备市场收入份额，依产品划分 (%)
  • 脊髓刺激器
  • 深部脑部刺激器
  • 荐神经刺激器
  • 迷走神经刺激器
  • 其他的

第 8 章：全球神经刺激设备市场 - 2030 年收入与预测 -按应用

  • 概述
  • 2022 年和 2030 年神经刺激设备市场收入份额，按应用划分 (%)
  • 疼痛管理
  • 癫痫
  • 尿失禁和大便失禁
  • 帕金森氏症
  • 其他的

第 9 章：全球神经刺激设备市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年神经刺激设备市场收入份额（按最终用户划分）（%）
  • 医院
  • 专科诊所
  • 其他的

第 10 章：神经刺激设备市场 - 2030 年收入与预测 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：神经刺激设备市场-产业格局

  • 概述
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 12 章：公司简介

  • Medtronic Plc
  • Boston Scientific Corp
  • Abbott Laboratories
  • Nevro Corp
  • LivaNova Plc
  • Synapse Biomedical Inc.
  • Nalu Medical, Inc
  • ElectroCore Inc
  • MicroTransponder Inc.
  • Mainstay Medical

第 13 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00002778

The neurostimulation devices market is projected to reach US$ 11.825 billion in 2030 from US$ 5.802 billion in 2022. The market is estimated to grow with a CAGR of 9.3% from 2022 to 2030. The growing prevalence of neurological diseases and increasing cases of spinal cord injury are the key driving factors behind the neurostimulation devices market development. However, lack of expert professionals is hampering the neurostimulation devices market growth.

Rising Demand for Noninvasive Treatment to Boost the Neurostimulation Devices Market in Future

Neurostimulation is a rapidly evolving field that uses targeted electrical, mechanical, magnetic, or thermal stimulation of the nervous system to alter the properties of firing neuronal and internal neuronal connectivity to treat various neurological disorders. Noninvasive neurostimulation devices include electroconvulsive therapy (ECT), transcutaneous electrical nerve stimulation (TENS), transcranial electrical stimulation (TES), transcranial direct current stimulation (tDCS), transcranial alternating current stimulation (tACS), static magnetic stimulation, random sound stimulation, peripheral nerve stimulation, ultrasound, and focused ultrasound (FUS), including cranial nerve stimulation. Noninvasive neurostimulation techniques are the most developed in psychiatry.

Patients and healthcare providers increasingly prefer noninvasive or minimally invasive treatment options as they are convenient, painless, safe, and have minimal side effects. In addition, it is widely used in neurological diseases. Noninvasive treatments aim to improve the quality of life and reduce the impact of speech, swallowing, and cognitive problems. Therefore, growing demand for noninvasive treatments would significantly fuel the neurostimulation devices market growth in the future.

The government is educating people about stroke and offering improved treatment, medical technology, and enhanced healthcare coverage and healthcare environment. Also, the country has invested more in preventing and treating noncommunicable diseases. Additionally, as per the data of WHO, ~95% of the population of China is insured in rural and urban areas, as the government introduced two insurance programs for low-income groups: the New Rural Cooperative Medical System (NRCMS) and Urban Resident Basic Medical Insurance (URBMI). The programs were launched as the cost of health is one of the significant expenses for most of the population. These initiatives by the Chinese government would encourage the population to undergo surgeries to improve health. The neurostimulation devices market is also expected to grow due to the rising development of the medical device industry in countries such as Japan and China. In addition, innovative technology trends in neurology and the rapid adoption of artificial intelligence (AI) and machine learning (ML) are a few factors that drive the market in the region.

Furthermore, the neurostimulation devices market growth in the country is attributed to the rising prevalence of stroke and increasing incidence. Neurosurgery requires advanced equipment and highly qualified medical professionals. Germany has highly qualified neurosurgeons; they follow the latest protocols and surgical procedures. Neurology centers in the country have the most modern diagnostic and minimally invasive surgical devices that meet international quality standards.

According to the data published in the Burden of Stroke in Europe report conducted by King's College London for the Stroke Alliance for Europe, Germany records around 88,922 stroke cases annually, which is 51.7 strokes per 100,000 inhabitants. The prevalence of stroke in Germany was ~ 526,774 that accounts for 338.5 strokes per 100,000 residents. Germany also has a significant mortality rate of stroke, i.e., 75,861 deaths due to stroke per year. According to the Burden of Stroke in Europe report, it is expected that stroke cases will increase by 30% by 2035, and the prevalence of stroke will grow to 19% by the end of 2035.approximately 400,000 people were affected with the disease in Germany in December 2022, and the numbers are increasing due to demographic aging. More and more people, including younger people, suffer from neurodegenerative diseases; in Germany, more than 2 million people have dementia or Parkinson's. According to the German Association for Alzheimer's Patients, in 2020, 9,450 deaths were caused due to Alzheimer's, recording the highest figure. The increase in hospitalizations and deaths with Alzheimer's diagnosis is highly dependent on the aging population in Germany. In Germany, people aged 65 and above had increased by ~33% and reached 18.3 million in 2020.

Thus, significantly growing incidence of stroke and rising aging population resulting in growing cases of neurological disorders drive the neurostimulation devices market growth in Germany. Furthermore, supportive government initiatives and research in neurology also boost market growth. Therefore, the factors mentioned above are likely to contribute to the neurostimulation devices market growth during 2022-2030.

The neurostimulation devices market is segmented on the basis of product, application, end user, and geography. Based on product, the market is segmented into spinal cord stimulator, deep brain stimulator, sacral nerve stimulator, vagus nerve stimulator, and others. The spinal cord stimulator segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by application, is segmented into pain management, epilepsy, urinary and fecal incontinence, Parkinson's disease, and others. The pain management segment held a larger market share in 2022 and the same is anticipated to register a higher CAGR during 2022-2030. The neurostimulation devices market, by end user, is bifurcated into hospitals, specialty clinics, and others. The hospitals segment held the largest share of the market in 2022 and specialty clinics segment is anticipated to register the highest CAGR in the market during 2022-2030. Specialty clinics are centers of excellence assured to deliver high standards of clinical outcomes. These centers are dedicated to diagnosing, treating, and managing neurological disorders and employ highly trained doctors, paramedics, and nursing personnel with specialized skills. Besides adhering to predefined protocols using high-end equipment, better service quality adds value to patients more than other facilities. These clinics streamline services and enhance convenient care.

In addition, specialty clinics provide medically recommended and supervised treatments in a relaxing and calming environment. These clinics also help to educate people regarding daily care routines for patients who have Parkinson's disease and Alzheimer's disease, tremors, and other such conditions, apart from providing several diagnostic procedures. These patients might undergo testing of motor symptoms by taking medications with gaps to assess the disease severity. Factors such as cost-effectiveness and shorter waiting times fuel the segment growth.

A global rise in the prevalence of these conditions has led to a growing number of patients visiting specialty clinics to diagnose and treat these conditions, with an increasing number of specialty clinics on the global level that offer better treatment and specialized services. In addition, the market growth is attributable to the growing penetration rate of specialty clinics across the globe. For instance, in July 2022, the neurology teams of Ohio State University Wexner Medical Center opened a new specialty clinic, the Parkinson's Disease Multidisciplinary Clinic. The clinic acts as a "one-stop shop" for Parkinson's disease patients to receive all the care they need without taking multiple appointments in different locations. At the clinic, patients can address symptoms such as stiffness, memory difficulties, unsteadiness/poor coordination, tremors, and fatigue with a team that includes therapists, neuropsychologists, subspecialty-trained movement neurologists, and advanced practice providers.

The Food and Drug Administration (FDA), National Cancer Institute (NCI), Ministry of Health and Prevention (MoHAP), and National Transformation Program (NTP) are among some of the primary and secondary sources referred to while preparing the report on the neurostimulation devices market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the neurostimulation devices market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the neurostimulation devices market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Neurostimulation Devices Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Neurostimulation Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Global PEST Analysis

5. Neurostimulation Devices Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Prevalence of Neurological Disorders
    • 5.1.2 Rising Cases of Spinal Cord Injury
  • 5.2 Market Restraints
    • 5.2.1 Lack of Expert Professionals
  • 5.3 Market Opportunities
    • 5.3.1 Growing Advances and Approvals for Neurostimulation Devices
  • 5.4 Future Trends
    • 5.4.1 Rising Demand for Noninvasive Treatment
  • 5.5 Impact Analysis

6. Neurostimulation Devices Market - Global Market Analysis

  • 6.1 Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

7. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Spinal Cord Stimulator
    • 7.3.1 Overview
    • 7.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Deep Brain Stimulator
    • 7.4.1 Overview
    • 7.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Sacral Nerve Stimulator
    • 7.5.1 Overview
    • 7.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Vagus Nerve Stimulator
    • 7.6.1 Overview
    • 7.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

  • 8.1 Overview
  • 8.2 Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Pain Management
    • 8.3.1 Overview
    • 8.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Epilepsy
    • 8.4.1 Overview
    • 8.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Urinary and Fecal Incontinence
    • 8.5.1 Overview
    • 8.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Parkinson's Disease
    • 8.6.1 Overview
    • 8.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Specialty Clinics
    • 9.4.1 Overview
    • 9.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Neurostimulation Devices Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 10.1 North America: Neurostimulation Devices Market
    • 10.1.1 Overview
    • 10.1.2 North America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 North America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.1.2.2 North America: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.1.2.3 North America: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.1.3 North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.1.3.1 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.2 US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.2.1 US: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.2.2 US: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.2.3 US: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.3.3 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.4 Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.4.1 Canada: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.4.2 Canada: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.4.3 Canada: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.1.3.5 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.1.3.6 Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.6.1 Mexico: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.1.3.6.2 Mexico: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.1.3.6.3 Mexico: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.2 Europe: Neurostimulation Devices Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.2.2.1 Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.2.2.2 Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.2.2.3 Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.2.3 Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.2.3.1 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.2 Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.2.1 Germany: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.2.2 Germany: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.2.3 Germany: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.3 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.4 UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.4.1 UK: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.4.2 UK: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.4.3 UK: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.5 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.6 France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.6.1 France: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.6.2 France: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.6.3 France: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.7 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.8 Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.8.1 Italy: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.8.2 Italy: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.8.3 Italy: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.9 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.10 Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.10.1 Spain: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.10.2 Spain: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.10.3 Spain: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.2.3.11 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.2.3.12 Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.12.1 Rest of Europe: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.2.3.12.2 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.2.3.12.3 Rest of Europe: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.3 Asia Pacific: Neurostimulation Devices Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.3.2.1 Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.3.2.2 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.3.2.3 Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.3.3 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.3.3.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.3.3.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.3.3.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.3.3.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.3.3.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.4 Middle East & Africa Neurostimulation Devices Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.4.2.1 Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.4.2.2 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
      • 10.4.2.3 Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
    • 10.4.3 Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
      • 10.4.3.1 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.2 Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.2.1 Saudi Arabia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.2.2 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.2.3 Saudi Arabia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.3 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.4 South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.4.1 South Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.4.2 South Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.4.3 South Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.5 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.6 UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.6.1 UAE: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.6.2 UAE: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.6.3 UAE: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
      • 10.4.3.7 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.4.3.8 Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.8.1 Rest of Middle East & Africa: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.4.3.8.2 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)
        • 10.4.3.8.3 Rest of Middle East & Africa: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)
  • 10.5 South & Central America: Neurostimulation Devices Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.5.2.1 South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
      • 10.5.2.2 South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
      • 10.5.2.3 South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
    • 10.5.3 South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
      • 10.5.3.1 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.2 Brazil: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.2.1 Brazil: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.2.2 Brazil: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.2.3 Brazil: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
      • 10.5.3.3 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.4 Argentina: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.4.1 Argentina: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.4.2 Argentina: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.4.3 Argentina: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)
      • 10.5.3.5 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)
      • 10.5.3.6 Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.6.1 Rest of South & Central America: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)
        • 10.5.3.6.2 Rest of South & Central America: Neurostimulation Devices Market, By Application, 2020-2030 (US$ Million)
        • 10.5.3.6.3 Rest of South & Central America: Neurostimulation Devices Market, By End User, 2020-2030 (US$ Million)

11. Neurostimulation Devices Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Boston Scientific Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Abbott Laboratories
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Nevro Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 LivaNova Plc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Synapse Biomedical Inc.
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Nalu Medical, Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 ElectroCore Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MicroTransponder Inc.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Mainstay Medical
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Neurostimulation Devices Market Segmentation
  • Table 2. North America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. North America Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. US Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. US Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. US Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. Canada Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. Canada Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. Canada Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. Mexico Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Mexico Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Mexico Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Germany Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Germany Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Germany Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. UK Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. UK Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. UK Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. France Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. France Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. France Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Italy Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Italy Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Italy Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Europe Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Asia Pacific Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 44. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Saudi Arabia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. Saudi Arabia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. Saudi Arabia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. South Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. South Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. South Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. UAE Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. UAE Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. UAE Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. Rest of Middle East & Africa Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. Rest of Middle East & Africa Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. Rest of Middle East & Africa Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. South & Central America Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Brazil Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Brazil: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Brazil: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Argentina Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Argentina: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Argentina: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. Rest of South & Central Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. Rest of South & Central America: Neurostimulation Devices Market, By Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. Rest of South & Central America: Neurostimulation Devices Market, By End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. Organic Developments Done by Companies
  • Table 84. Inorganic Developments Done by Companies
  • Table 85. Glossary of Terms, Neurostimulation Devices Market

List Of Figures

  • Figure 1. Neurostimulation Devices Market Segmentation, By Geography
  • Figure 2. Global - PEST Analysis
  • Figure 3. Neurostimulation Devices Market: Key Industry Dynamics
  • Figure 4. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints
  • Figure 5. Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030
  • Figure 6. Global Neurostimulation Devices Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 8. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 14. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 20. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. North America: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 24. North America Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 26. US: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Canada: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Mexico: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Europe: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 32. Germany: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. UK: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. France: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Italy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Spain: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Rest of Europe: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 39. Asia Pacific Neurostimulation Devices Market Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 41. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 42. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 44. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Middle East & Africa: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 48. Middle East & Africa Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Middle East & Africa: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)
  • Figure 50. Saudi Arabia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 51. South Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. UAE: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 53. Rest of Middle East & Africa: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. South & Central America: Neurostimulation Devices Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 55. South & Central America: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 56. South & Central America: Neurostimulation Devices Market Share by Country - 2022 & 2030, (%)
  • Figure 57. Brazil: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 58. Argentina: Neurostimulation Devices Market- Revenue and Forecasts to 2030 (US$ Million)
  • Figure 59. Rest of South & Central America: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)